CareFusion (FRA:TCF) FCF Margin % : 10.29% (As of Dec. 2014)

View and export this data going back to . Start your Free Trial

What is CareFusion FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. CareFusion's Free Cash Flow for the three months ended in Dec. 2014 was €89 Mil. CareFusion's Revenue for the three months ended in Dec. 2014 was €867 Mil. Therefore, CareFusion's FCF Margin % for the quarter that ended in Dec. 2014 was 10.29%.

As of today, CareFusion's current FCF Yield % is 0.00%.

The historical rank and industry rank for CareFusion's FCF Margin % or its related term are showing as below:

FRA:TCF' s FCF Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 11.78
Current: 11.78

During the past 8 years, the highest FCF Margin % of CareFusion was 11.78%. The lowest was 0.00%. And the median was 0.00%.

FRA:TCF's FCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -7.13 vs FRA:TCF: 11.78

CareFusion FCF Margin % Historical Data

The historical data trend for CareFusion's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CareFusion FCF Margin % Chart

CareFusion Annual Data

Trend

Jun07

Jun08

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

FCF Margin %

Get a 7-Day Free Trial

15.34

5.17

15.15

14.34

15.33

CareFusion Quarterly Data
	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14
FCF Margin %	Get a 7-Day Free Trial															22.13	13.84	17.38	5.10	10.29

Competitive Comparison of CareFusion's FCF Margin %

For the Medical Instruments & Supplies subindustry, CareFusion's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CareFusion's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CareFusion's FCF Margin % distribution charts can be found below:

* The bar in red indicates where CareFusion's FCF Margin % falls into.

CareFusion FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

CareFusion's FCF Margin for the fiscal year that ended in Jun. 2014 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2014 )	/	Revenue (A: Jun. 2014 )
	=	433.504	/	2827.712
	=	15.33 %

CareFusion's FCF Margin for the quarter that ended in Dec. 2014 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2014 )	/	Revenue (Q: Dec. 2014 )
	=	89.21	/	866.959
	=	10.29 %

CareFusion FCF Margin % Related Terms

Thank you for viewing the detailed overview of CareFusion's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

CareFusion (FRA:TCF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CareFusion Corp (FRA:TCF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

CareFusion Corp a Delaware corporation was incorporated on January 14, 2009. It is a medical technology company. The Company offers a portfolio of products in the areas of medication management, infection prevention, operating room and procedural effectiveness, and respiratory care. Its primary product brands includes: Alaris intravenous (IV) infusion systems, Pyxis and Rowa automated medication dispensing and supply management systems, AVEA, Vela and LTV Series respiratory ventilators, ChloraPrep skin antiseptic products, MedMined data mining surveillance software and analytics, Vital Signs single-use consumables for respiratory care and anesthesiology, and Jaeger and SensorMedics cardiopulmonary diagnostic equipment. The Company operates in two business segments: Medical Systems and Procedural Solutions. In the Medical Systems segment, the Company develops, manufacture and market capital equipment and related supplies for medication management, which includes our infusion and medication dispensing technologies, supply management, as well as respiratory ventilation and diagnostic technologies. In the Procedural Solutions segment, the Company develops, manufacture and market single-use skin antiseptic and other patient-preparation products, specialty IV infusion valves, administration sets and accessories, IV catheters, IV drug preparation products, reusable surgical instruments, non-dedicated ventilator circuits and other disposables used for providing respiratory therapy, as well as single-use consumables for respiratory care and anesthesiology. The Company's competitors includes Baxter International; B. Braun; Fresenius Kabi; Hospira; Omnicell; McKesson; DrÃ¤ger; MAQUET, 3M; ICU Medical; Becton, Dickinson; Baxter International; B. Braun; Hospira; Smiths Medical; CR Bard; Integra Life Sciences; and Teleflex. The Company's operations are subject to the Federal Food, Drug and Cosmetic Act (FDC Act), as implemented and enforced by the United States Food and Drug Administration (FDA).